{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:26:28Z","timestamp":1790072788338,"version":"4.0.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"52","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Amyloidosis is particularly difficult to diagnose because the signs and symptoms are subtle. Additionally, there are no specific imaging or laboratory tests, except histopathology. Although it is considered to be a systemic disorder, a small portion of cases may be localized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Introduction of the case:<\/jats:title>\n                    <jats:p>A 54-year-old man presented with nonspecific symptoms (jaundice and back pruritus). Biochemical tests showed a high level of bilirubin and elevated serum tumor markers (CA19\u20139 and CA125). Routine imaging showed hepatomegaly without heterogeneous enhancement. Liver biopsy confirmed the diagnosis of hepatic amyloidosis. No cardiac or renal involvement was found. The patient accepted treatment involving oral chemotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>A rare and unique presentation of hepatic amyloidosis was highlighted in this case.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000005645","type":"journal-article","created":{"date-parts":[[2016,12,29]],"date-time":"2016-12-29T14:06:09Z","timestamp":1483020369000},"page":"e5645","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Primarily isolated hepatic involvement of amyloidosis"],"prefix":"10.1097","volume":"95","author":[{"given":"Lei","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Min","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20260907","doi-asserted-by":"crossref","first-page":"437","DOI":"10.15403\/jgld.2014.1121.234.hamy","article-title":"Primary hepatic amyloidosis presenting as nodular masses on the background of diffuse infiltration and extreme liver stiffness on MR elastography","volume":"23","author":"Srinivasan","year":"2014","journal-title":"J Gastrointestin Liver Dis"},{"key":"R2-13-20260907","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3816\/CLML.2010.n.027","article-title":"Pitfalls in the diagnosis of primary amyloidosis","volume":"10","author":"Chee","year":"2010","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"R3-13-20260907","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/bjh.13656","article-title":"Disease-free survival following high dose or standard dose therapy in patients with amyloidosis","volume":"174","author":"Kiel","year":"2015","journal-title":"Br J Haematol"},{"key":"R4-13-20260907","first-page":"16137","article-title":"Primary amyloidosis mimicking Crohn's disease: a case report","volume":"8","author":"Wang","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"R5-13-20260907","first-page":"1133","article-title":"Immunoglobulin light chain amyloidosis: 214 update on diagnosis, prognosis, and treatment","volume":"89","author":"Morie","year":"2014","journal-title":"Am J Hematol"},{"key":"R6-13-20260907","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrrheum.2010.84","article-title":"Systemic amyloidosis: a challenge for the rheumatologist","volume":"6","author":"Perfetto","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"R7-13-20260907","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0037-198X(86)90027-1","article-title":"Amyloidosis: an overview","volume":"21","author":"Scott","year":"1986","journal-title":"Semin Roentgenol"},{"key":"R8-13-20260907","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/archinte.1988.00380040169024","article-title":"Utility of subcutaneous fat aspiration for the diagnosis of systemic amyloidosis (immunoglobulin light chain)","volume":"148","author":"Gertz","year":"1988","journal-title":"Arch Intern Med"},{"key":"R9-13-20260907","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/bjh.13805","article-title":"Recent advances in the management of AL amyloidosis","volume":"172","author":"Kastritis","year":"2016","journal-title":"Br J Haematol"},{"key":"R10-13-20260907","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.3324\/haematol.2013.102764","article-title":"Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics","volume":"99","author":"Vrana","year":"2014","journal-title":"Haematologica"},{"key":"R11-13-20260907","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3109\/13506120308999000","article-title":"An on-line assay forclinical detection of amyloidogenic transthyretin variants directly from serum","volume":"10","author":"Bergen","year":"2003","journal-title":"Amyloid"},{"key":"R12-13-20260907","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1007\/s00261-015-0519-4","article-title":"Amyloidosis of the liver on shear wave elastography: case report and review of literature","volume":"40","author":"Trifanov","year":"2015","journal-title":"Abdom Imaging"},{"key":"R13-13-20260907","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0002-9343(97)89487-9","article-title":"Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only","volume":"100","author":"Skinner","year":"1996","journal-title":"Am J Med"},{"key":"R14-13-20260907","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1056\/NEJM199704243361702","article-title":"A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine","volume":"336","author":"Kyle","year":"1997","journal-title":"N Engl J Med"},{"key":"R15-13-20260907","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3324\/haematol.2013.095463","article-title":"Oral melphalan and dexamethasone grants extended survival with minimal toxicity in AL amyloidosis: long-term results of a risk-adapted approach","volume":"99","author":"Palladini","year":"2014","journal-title":"Haematologica"},{"key":"R16-13-20260907","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1182\/blood-2006-07-035352","article-title":"Safety and efficacy of risk-adapted cyclophosphamide, thalidomide, and dexamethasone in systemic AL amyloidosis","volume":"109","author":"Wechalekar","year":"2007","journal-title":"Blood"},{"key":"R17-13-20260907","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1182\/blood-2010-07-294405","article-title":"Lenalidomide in comb ination with melphalan and dexamethasone in patients with newly diagnosed AL amyloidosis: a multicenter phase 1\/2 dose escalation study","volume":"116","author":"Moreau","year":"2010","journal-title":"Blood"},{"key":"R18-13-20260907","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3324\/haematol.2012.075192","article-title":"lenalidomide and dexamethasone for the treatment of immunoglo bulin light chain amyloidosis: Results of a phase II trial","volume":"98","author":"Sanchorawala","year":"2013","journal-title":"Haematologica"},{"key":"R19-13-20260907","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1182\/blood-2012-02-413161","article-title":"Activity of pomalidomide in patients with immunoglobulin light-chain amyloidosis","volume":"119","author":"Dispenzieri","year":"2012","journal-title":"Blood"},{"key":"R20-13-20260907","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00277-010-1062-6","article-title":"Efficacy of the combination of bortezomib and dexamethasone in systemic AL amyloidosis","volume":"90","author":"Lamm","year":"2011","journal-title":"Ann Hematol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00005792-201612300-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:03:34Z","timestamp":1788797014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005792-201612300-00013"}},"subtitle":["A case report and overview"],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":20,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000005645","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12]]}}}